| Literature DB >> 31767961 |
Ofira Zloto1,2, Tal Koval3,4, Arkadi Yakirevich4,5, Guy J Ben Simon3,4, Alon Weissman3,4, Elad Ben Artsi3,4, Joseph Ben Shoshan4,5, Ayelet Priel3,4.
Abstract
BACKGROUND: The nasal mucosa is sacrificed in conventional endoscopic dacryocystorhinostomies (EDCRs). Some surgeons, however, modify the technique by elevating a mucosal flap prior to creating the osteotomy with the aim of preserving the mucosa. To our knowledge, no clear-cut benefit of a mucosal flap has been established. The aim of this study is to examine the differences in surgical techniques and success rates of EDCRs with and without mucosal flap preservation.Entities:
Mesh:
Year: 2019 PMID: 31767961 PMCID: PMC7468247 DOI: 10.1038/s41433-019-0716-4
Source DB: PubMed Journal: Eye (Lond) ISSN: 0950-222X Impact factor: 3.775
Demographics and medical history
| Variable | WOF group 51 patients ( | FP group 56 patients ( | |
|---|---|---|---|
| Age in years (mean) | 54.3 | 48.2 | 0.117 |
| Gender | |||
| Male | 5 (9.8) | 16 (28.57) | 0.021* |
| Female | 46 (90.2) | 40 (71.42) | |
| Hypertension | 0.395 | ||
| Yes | 14 (27.4) | 11 (19.6) | |
| No | 37 (72.6) | 45 (80.4) | |
| Diabetes mellitus | 0.933 | ||
| Yes | 8 (15.7) | 11 (19.6) | |
| No | 43 (84.3) | 45 (80.4) | |
| Smoking | 0.293 | ||
| Yes | 0 (0) | 1 (1.8) | |
| No | 51 (100) | 55 (98.2) | |
| Rheumatic diseases | |||
| Yes | 0 (0) | 0 (0) | |
| No | 51 (100) | 56 (100) | |
| aOphthalmic diseases | 0.469 | ||
| Yes | 4 (7.9) | 8 (14.3) | |
| No | 47 (92.1) | 48 (85.7) | |
| bPrevious ophthalmic surgeries | 0.685 | ||
| Yes | 7 (13.7) | 10 (17.8) | |
| No | 44 (86.3) | 46 (82.2) | |
| Previous nose/sinus diseases | 0.652 | ||
| Yes | 5 (9.8) | 7 (12.5) | |
| No | 46 (90.2) | 49 (87.5) | |
WOF Group no preservation of mucosal flap, FP Group with mucosal flap preservation
*Significant
aOphthalmic diseases (retina, cornea, glaucoma)
bOphthalmic surgeries (cataract, retina, cornea, glaucoma)
Surgical data
| Variable | WOF group (56 cases) ( | FP group (61 cases) ( | |
|---|---|---|---|
| Eye | 0.352 | ||
| Right | 30 (53.6) | 36 (59.9) | |
| Left | 26 (46.4) | 25 (40.1) | |
| Lacrimal tubing | 0.719 | ||
| Yes | 54 (96.4) | 58 (95.0) | |
| No | 2 (3.6) | 3 (5) | |
| Stenting period (weeks) | 9 | 11 | 0.229 |
| Surgical success | 0.478 | ||
| Yes | 46 (82.2) | 53 (86.8) | |
| No | 10 (17.8) | 8 (13.2) | |
| Revision surgery | 5 | 3 | 0.582 |
WOF Group no preservation of mucosal flap, FP Group with mucosal flap preservation